Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 31

Trial Status

Other1

Role Distribution

Principal Investigator1
PI Rate100%

Activity Timeline

Clinical Trials (1)

NCT02025036Phase 3Unknown
Chemoradiotherapy of Capecitabine With or Without Oxaliplatin Versus Cisplatin-5-FU for Esophageal Squamous Cancer
Stage II Esophageal Squamous Cell CarcinomaStage III Esophageal Squamous Cell Carcinoma
PrincipalinvestigatorStart date: 2014-10-01

Research Network

Collaboration Network

25 collaborators·50 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

Anyang Tumour Hospital of Henan province

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Jing Ren, Master

The First Affiliated Hospital of Henan University of Science and Technology

Moderately Similar
3 trials

Shared therapeutic areas:

Stage III Esophageal Squamous Cell CarcinomaStage II Esophageal Squamous Cell Carcinoma

Worked with same sponsors:

The First Affiliated Hospital of Henan University of Science and Technology
Similarity Score30%

Weijiao Yin, Master

The First Affiliated Hospital of Henan University of Science and Technology

Moderately Similar
3 trials

Shared therapeutic areas:

Stage III Esophageal Squamous Cell CarcinomaStage II Esophageal Squamous Cell Carcinoma

Worked with same sponsors:

The First Affiliated Hospital of Henan University of Science and Technology
Similarity Score30%

Wei Wang, Master

The First Affiliated Hospital of Henan University of Science and Technology

Moderately Similar
3 trials

Shared therapeutic areas:

Stage III Esophageal Squamous Cell CarcinomaStage II Esophageal Squamous Cell Carcinoma

Worked with same sponsors:

The First Affiliated Hospital of Henan University of Science and Technology
Similarity Score30%

Shegan Gao, Doctor

The First Affiliated Hospital of Henan University of Science and Technology

Moderately Similar
4 trials

Shared therapeutic areas:

Stage III Esophageal Squamous Cell CarcinomaStage II Esophageal Squamous Cell Carcinoma

Worked with same sponsors:

The First Affiliated Hospital of Henan University of Science and Technology
Similarity Score30%

Guoqiang Kong, Master

The First Affiliated Hospital of Henan University of Science and Technology

Moderately Similar
3 trials

Shared therapeutic areas:

Stage III Esophageal Squamous Cell CarcinomaStage II Esophageal Squamous Cell Carcinoma

Worked with same sponsors:

The First Affiliated Hospital of Henan University of Science and Technology
Similarity Score30%

Ruinuo Jia, Master

The First Affiliated Hospital of Henan University of Science and Technology

Moderately Similar
3 trials

Shared therapeutic areas:

Stage III Esophageal Squamous Cell CarcinomaStage II Esophageal Squamous Cell Carcinoma

Worked with same sponsors:

The First Affiliated Hospital of Henan University of Science and Technology
Similarity Score30%

Ruina Yang, Master

The First Affiliated Hospital of Henan University of Science and Technology

Moderately Similar
3 trials

Shared therapeutic areas:

Stage III Esophageal Squamous Cell CarcinomaStage II Esophageal Squamous Cell Carcinoma

Worked with same sponsors:

The First Affiliated Hospital of Henan University of Science and Technology
Similarity Score30%

Jiachun Sun, Doctor

The First Affiliated Hospital of Henan University of Science and Technology

Moderately Similar
3 trials

Shared therapeutic areas:

Stage III Esophageal Squamous Cell CarcinomaStage II Esophageal Squamous Cell Carcinoma

Worked with same sponsors:

The First Affiliated Hospital of Henan University of Science and Technology
Similarity Score30%

Xiaozhi Yuan, Master

The First Affiliated Hospital of Henan University of Science and Technology

Moderately Similar
4 trials

Shared therapeutic areas:

Stage III Esophageal Squamous Cell CarcinomaStage II Esophageal Squamous Cell Carcinoma

Worked with same sponsors:

The First Affiliated Hospital of Henan University of Science and Technology
Similarity Score30%

Xinshuai Wang, Doctor

The First Affiliated Hospital of Henan University of Science and Technology

Moderately Similar
3 trials

Shared therapeutic areas:

Stage III Esophageal Squamous Cell CarcinomaStage II Esophageal Squamous Cell Carcinoma

Worked with same sponsors:

The First Affiliated Hospital of Henan University of Science and Technology
Similarity Score30%

Publications (0)

No publications found for this investigator.

Clinical Trials (1)

Showing 1 of 1 trials

NCT02025036Phase 3PrincipalInvestigator

Chemoradiotherapy of Capecitabine With or Without Oxaliplatin Versus Cisplatin-5-FU for Esophageal Squamous Cancer

Stage II Esophageal Squamous Cell CarcinomaStage III Esophageal Squamous Cell Carcinoma
Unknown

All 1 trials loaded